What is an Efficient and Affordable Trastuzumab Therapy in a Middle-Income Country? - Adjuvant Therapy with Trastuzumab in Management of Early HER2-Positive Breast Cancer in Iran
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.2147
https://www.valueinhealthjournal.com/article/S1098-3015(16)33513-6/fulltext
Section Title :
Disease-Specific Studies
Section Order :
2035
First Page :
A721
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33513-6&doi=10.1016/j.jval.2016.09.2147